MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales and maturities
of marketable...
$353,869K
Proceeds from exercise of
common stock options
$2,329K
Net cash provided by
investing activities
$192,191K
Net cash provided by
financing activities
$2,329K
Effect of exchange rate
changes on cash, cash...
$1,320K
Canceled cashflow
$161,678K
Net increase in
cash, cash...
$28,405K
Canceled cashflow
$167,435K
Purchases of marketable
securities
$157,829K
Purchases of property and
equipment, net of disposals
$3,849K
Stock-based compensation
expense
$34,018K
Accrued liabilities
$4,287K
Accounts payable
$3,584K
Accrued interest, net of
interest received on...
$1,980K
Amortization of debt issuance
costs and discount
$449K
Amortization and interest
accretion related to...
$408K
Depreciation and
amortization expense
$386K
Net cash used in
operating activities
-$167,435K
Canceled cashflow
$45,112K
Net loss
-$94,391K
Trade receivables,
net
$52,880K
Prepaid expenses and
other assets
$40,649K
Inventory
$22,187K
Other non-cash items,
net
$3,052K
Back
Back
Cash Flow
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
source: myfinsight.com